Mark E. Smith

3.0k citations

73 papers · 2.3k indexed · 1 hit paper · h-index 22

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
- Vascular Tumors and Angiosarcomas
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Oncology 29
- Viral-associated cancers and disorders 10
- Vascular Tumors and Angiosarcomas 7
Pulmonary and Respiratory Medicine 22
- Sarcoma Diagnosis and Treatment 12

Co-authors: Walter F. Bodmer (4 shared papers)Nanda R. Rodrigues (1 shared paper)I B Kerr (1 shared paper)Andrew Rowan (1 shared paper)Julian Gannon (1 shared paper)David P. Lane (1 shared paper)Cyril Fisher (6 shared papers)Sharon W. Weiss (2 shared papers)
Journals: Histopathology (11 papers)Journal of Clinical Pathology (7 papers)The Journal of Pathology (5 papers)Proceedings of the National Academy of Sciences (4 papers)Archives of Pathology & Laboratory Medicine (2 papers)
Partner nations: United Kingdom United States Tanzania

In The Last Decade

Mark E. Smith

70 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

p53 mutations in colorectal cancer. 1990 · 895 citations

Peers

Countries citing papers authored by Mark E. Smith

Since Specialization

Citations

This map shows the geographic impact of Mark E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smith more than expected).

Fields of papers citing papers by Mark E. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smith. The network helps show where Mark E. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Smith Line = papers co-authored together Mark E. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	p53 mutations in colorectal cancer. Proceedings of the National Academy of Sciences ·Nanda R. Rodrigues, Andrew Rowan, Mark E. Smith, I B Kerr, Walter F. Bodmer, Julian Gannon, David P. Lane Hit paper breakdown →	1990	895
2	Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts The American Journal of Surgical Pathology ·Mark E. Smith, Cyril Fisher, Sharon W. Weiss	1996	115
3	Amino Terminal Sequence of the Major Component of Human Lymphoblastoid Interferon Science ·Kathryn C. Zoon, Mark E. Smith, Pamela J. Bridgen, Christian B. Anfinsen, Michael W. Hunkapiller, Leroy Hood	1980	113
4	Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proceedings of the National Academy of Sciences ·Mark E. Smith, S. G. E. Marsh, JuliaG. Bodmer, K. Gelsthorpe, Walter F. Bodmer	1989	104
5	Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. Journal of Clinical Pathology ·Mark E. Smith, Jordan Thomas	1990	79
6	Purification and partial characterization of human lymphoblast interferon. Proceedings of the National Academy of Sciences ·Kathryn C. Zoon, Mark E. Smith, Pamela J. Bridgen, Dorothy Zur Nedden, Christian B. Anfinsen	1979	62
7	Evaluation of CD68 and Other Histiocytic Antigens in Angiomatoid Malignant Fibrous Histiocytoma The American Journal of Surgical Pathology ·Mark E. Smith, Michael J. Costa, Sharon W. Weiss	1991	55
8	The molecular histology of neoplasia: the role of the cadherin/catenin complex Histopathology ·Mark E. Smith, Massimo Pignatelli	1997	53
9	Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Human Pathology ·Lesley Christie, Alan Evans, Susan E. Bray, Mark E. Smith, Neil M. Kernohan, David A. Levison, John R. Goodlad	2005	50
10	Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment. Proceedings of the National Academy of Sciences ·Heinz Arnheiter, M. Ohno, Mark E. Smith, Bernd Gutte, Kathryn C. Zoon	1983	47
11	DNA content and prognosis of non-Hodgkin's lymphoma British Journal of Cancer ·Diana Morgan, J. M. S. Williamson, Philip Quirke, A D Clayden, Mark E. Smith, Claire O’Brien, Devin Allison, J. A. Child, C C Bird	1987	45
12	Modulation of E‐cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas International Journal of Cancer ·Gerard Cowley, Mark E. Smith	1995	38
13	Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Decreases Monocyte Chemoattractant Protein-1 Expression and Neointimal Hyperplasia in the Rabbit Atherosclerotic Balloon Injury Model Journal of Cardiovascular Pharmacology ·Kai Wang, Khaldoun G. Tarakji, Zhongmin Zhou, Ming Zhang, Farhad Forudi, Xiaorong Zhou, Alane Koki, Mark E. Smith, Bradley T. Keller, Eric J. Topol, A.Michael Lincoff, Marc S. Penn	2004	37
14	CADHERIN EXPRESSION IN MELANOCYTIC NAEVI AND MALIGNANT MELANOMAS The Journal of Pathology ·Gerard Cowley, Mark E. Smith	1996	36
15	Epithelioid sarcoma: presence of vascular‐endothelial cadherin and lack of epithelial cadherin Histopathology ·Mark E. Smith, Juliane Brown, Cyril Fisher	1998	34
16	Myxoid variant of follicular dendritic cell sarcoma arising in the breast Annals of Diagnostic Pathology ·Cyril Fisher, Bjarki Magnússon, Sverrir Harðarson, Mark E. Smith	1999	34
17	Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) BMC Cancer ·Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, Penny Johnson, Marta E. Polak, Louise A. Knight, Zoe Goldthorpe, Katharine Peregrin, M.M. Gyi, Paul Modi, Joe Rahamim, Mark E. Smith, Khalid Amer, Bruce Addis, Matthew Poole, Ajit Narayanan, T. Gulliford, Peter E. Andreotti, Ian A. Cree	2009	33
18	A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma Histopathology ·Margaret Ashton‐Key, TC Diss, P G Isaacson, Mark E. Smith	1995	31
19	Synovial sarcomas lack synovial differentiation Histopathology ·Mark E. Smith, Cyril Fisher, Lynne Wilkinson, Jo C. W. Edwards	1995	30
20	Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma. Journal of Clinical Pathology ·Mark E. Smith, C S Holgate, J. M. S. Williamson, I Grigor, Philip Quirke, C C Bird	1987	30

About Mark E. Smith

Mark E. Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Immunology and Molecular Biology, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Soft tissue tumor case studies (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Vascular Tumors and Angiosarcomas (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and T-cell and B-cell Immunology (5 papers). The work is most often cited by research in Oncology (1.1k citations), Pathology and Forensic Medicine (510 citations), Cancer Research (314 citations), Immunology (421 citations) and Biotechnology (135 citations). Mark E. Smith has collaborated with scholars based in United Kingdom, United States and Tanzania. Frequent co-authors include Walter F. Bodmer, Nanda R. Rodrigues, I B Kerr, Andrew Rowan, Julian Gannon, David P. Lane, Cyril Fisher, Sharon W. Weiss, Kathryn C. Zoon and Gerard Cowley. Their work appears in journals such as Histopathology, Journal of Clinical Pathology, The Journal of Pathology, Proceedings of the National Academy of Sciences and Archives of Pathology & Laboratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact